Skip to content

Total at other companies

Hinge Health, Inc. logo
Hinge Health, Inc.HNGE

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.08B-19.8%
Enterprise value$1.64B-8.5%
P/S1.1×-0.3×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's total?
Tandem Diabetes Care (TNDM) reported total of $391.01M in Q1 2026.
How has Tandem Diabetes Care's total changed year-over-year?
Tandem Diabetes Care's total increased by 24.4% year-over-year, from $314.19M to $391.01M.
What is the long-term trend for Tandem Diabetes Care's total?
Over 5 years (2020 to 2025), Tandem Diabetes Care's total has grown at a -12.4% compound annual growth rate (CAGR), from $390.25M to $201.08M.